Showing results (2121-2130 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 22, 2011
Familial pediatric endocrine tumorsSarinda Millar, Lisa Bradley, Deirdre E Donnelly, et al.
The Oncologist|October 5, 2011
Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER dataDianne Pulte, Adam Gondos, Hermann Brenner
The Oncologist|November 22, 2011
Age-specific administration of chemotherapy and long-term quality of life in stage II and III colorectal cancer patients: a population-based prospective cohortLina Jansen, Michael Hoffmeister, Jenny Chang-Claude, et al.
The Oncologist|June 11, 2011
Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?Marco Tucci, Stefania Stucci, Sabino Strippoli, et al.
The Oncologist|December 3, 2011
Toxicity as a biomarker of efficacy of molecular targeted therapies: focus on EGFR and VEGF inhibiting anticancer drugsRodrigo Dienstmann, Irene Braña, Jordi Rodon, et al.
The Oncologist|March 16, 2012
Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancerJoyce A O'Shaughnessy, Manfred Kaufmann, Friederike Siedentopf, et al.
The Oncologist|March 9, 2012
Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapyDaniel E Spratt, Mayuko Sakae, Nadeem Riaz, et al.
The Oncologist|February 24, 2012
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatientsAndreas F Hottinger, Anne-Claude C George, Michael Bel, et al.
The Oncologist|February 24, 2012
Palliative care consultation service and palliative care unit: why do we need both?Jan Gaertner, Sebastian Frechen, Markus Sladek, et al.
The Oncologist|April 19, 2012
Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complicationsMark A Lewis, Sylvia Jaramillo, Lewis Roberts, et al.
Pageof 571